Katarina Milicevic holds an MSc in Molecular Biology from Lund University and joined Redoxis in 2024. Her background includes practical experience with both in vivo and in vitro experimental techniques.
At Redoxis, Katarina contributes to the execution of in vivo studies across models of inflammation and autoimmune disease. Her work includes study procedures, data collection, and support of experimental workflows within preclinical research projects.
Her work contributes to the generation of reliable preclinical data supporting research programs in inflammation and immune-mediated diseases.
